S Hirohara

Summary

Country: USA

Publications

  1. doi request reprint Phase II study of gemcitabine in combination with regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer
    Tadashi Uwagawa
    Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
    Am J Clin Oncol 36:44-8. 2013
  2. doi request reprint A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer
    T Uwagawa
    Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
    Ann Oncol 20:239-43. 2009
  3. ncbi request reprint Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation
    Tadashi Uwagawa
    Department of Surgery, Jikei University School of Medicine, 3 25 8 Nishi shinbashi, Minato ku, Tokyo 105 8461, Japan
    Anticancer Res 29:3173-8. 2009
  4. doi request reprint Proton-pump inhibitor as palliative care for chemotherapy-induced gastroesophageal reflux disease in pancreatic cancer patients
    Tadashi Uwagawa
    Department of Surgery, Jikei University School of Medicine, Tokyo, Japan
    J Palliat Med 13:815-8. 2010

Collaborators

  • Tadashi Uwagawa
  • Katsuhiko Yanaga
  • Takeyuki Misawa
  • Takeshi Gocho
  • T Uwagawa
  • Shunichi Sadaoka
  • Nobuhiro Tsutsui
  • Ryusuke Ito
  • Tomonori Iida
  • Shigeki Wakiyama
  • Taro Sakamoto
  • T Sakamoto
  • R Ito
  • H Shiba
  • T Gocho
  • S Sadaoka
  • T Misawa
  • K Yanaga
  • S Wakiyama
  • Paul J Chiao

Detail Information

Publications4

  1. doi request reprint Phase II study of gemcitabine in combination with regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer
    Tadashi Uwagawa
    Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
    Am J Clin Oncol 36:44-8. 2013
    ....
  2. doi request reprint A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer
    T Uwagawa
    Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
    Ann Oncol 20:239-43. 2009
    ..The secondary end point was to assess therapeutic response...
  3. ncbi request reprint Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation
    Tadashi Uwagawa
    Department of Surgery, Jikei University School of Medicine, 3 25 8 Nishi shinbashi, Minato ku, Tokyo 105 8461, Japan
    Anticancer Res 29:3173-8. 2009
    ..In this study, whether or not nafamostat mesilate could enhance the anticancer effect of gemcitabine was investigated...
  4. doi request reprint Proton-pump inhibitor as palliative care for chemotherapy-induced gastroesophageal reflux disease in pancreatic cancer patients
    Tadashi Uwagawa
    Department of Surgery, Jikei University School of Medicine, Tokyo, Japan
    J Palliat Med 13:815-8. 2010
    ..GERD was diagnosed in 40% of the patients according to the Frequency Scale for Symptoms of GERD score, and RBZ therapy significantly improved their symptoms...